Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Ltd recorded one insider transaction over the past 90 days. On August 3, 2026, CEO Ivor Elrifi purchased 667,000 shares valued at $667,000. This acquisition occurs amid a 37.3% decline in the stock price over the last three months, with the current share price trading near its 52-week low.
Ticker: TLSA Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tiziana Life Sciences Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Elrifi Ivor Chief Executive Officer Officer
Transaction date
Purchase
Price
263.56
Quantity 35,692 +25.7%
Value US$3,196,923
Elrifi Ivor Chief Executive Officer Officer
Transaction date
Purchase
Price
121.64
Quantity 29,140 -4.1%
Value US$1,869,742
Elrifi Ivor Chief Executive Officer Officer
Transaction date
Purchase
Price
77.19
Quantity 87,030 +5.2%
Value US$4,285,570
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-06 2026-08-05 B Purchase

Chief Executive Officer

Officer
35,692 +25.7%
263.56
US$3,196,923
35,692 +25.7% 263.56 US$3,196,923
2026-08-06 2026-08-04 B Purchase

Chief Executive Officer

Officer
29,140 -4.1%
121.64
US$1,869,742
29,140 -4.1% 121.64 US$1,869,742
2026-08-05 2026-08-03 B Purchase

Chief Executive Officer

Officer
87,030 +5.2%
77.19
US$4,285,570
87,030 +5.2% 77.19 US$4,285,570